Page last updated: 2024-11-03

pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid and Metabolic Acidosis

pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid has been researched along with Metabolic Acidosis in 1 studies

pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid: a novel antagonist that selectively blocks P2 purinoceptor receptors; a useful tool to study co-transmission in tissues when ATP and coexisting neurotransmitters act in concert
5'-phosphopyridoxal-6-azobenzene-2,4-disulfonic acid : An arenesulfonic acid that is pyridoxal 5'-phosphate carrying an additional 2,4-disulfophenylazo substituent at position 6.

Research Excerpts

ExcerptRelevanceReference
" Dose-response curves were fit with nonlinear regression analysis to calculate the EC(50) and slope."1.33Acidosis attenuates P2X purinergic vasoconstriction in skeletal muscle arteries. ( Buckwalter, JB; Clifford, PS; Hamann, JJ; Kluess, HA, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kluess, HA1
Buckwalter, JB1
Hamann, JJ1
Clifford, PS1

Other Studies

1 other study available for pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid and Metabolic Acidosis

ArticleYear
Acidosis attenuates P2X purinergic vasoconstriction in skeletal muscle arteries.
    American journal of physiology. Heart and circulatory physiology, 2005, Volume: 288, Issue:1

    Topics: Acidosis; Adenosine Triphosphate; Animals; Arteries; Hydrogen-Ion Concentration; Male; Muscle, Skele

2005